|
|
8812-60 Avenue, Edmonton
Edmonton, Alberta T6E 6A6 Canada
phone:780-413-7152
fax:780-408-3040
|
|
| Symbol |
MS |
| Exchange |
TSX |
| Founded |
0 |
| Employees |
|
|
|
| www.biomsmedical.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Developing treatments for multiple sclerosis |
|
| Management |
| Dr. Kenneth Warren, Professor of Medicine (Neurology) at the University of Alberta, and Director; Ms. Ingrid Catz, Senior Scientist at the MS Patient Care and Research Clinic; Dr. Mark Freedman, Professor of Neurology at the University of Ottawa and Director of the Multiple Sclerosis Research; Dr. Carolyn Young, Consultant Neurologist at the Walton Centre for Neurology and Neurosurgery, Liverpool, and honorary senior lecture; Dr. Tomas Olsson, Professor of Molecular Medicine, and Senior Staff Physician of Neurology |
| |
|
|
|
|
|
|
|
| Keywords |
| dirucotide, haplotypes, immunological, synthetic peptide, autoimmune |
|
|
|
| Description |
|
It is a Canadian biotech company engaged in the development and commercialization of novel therapeutic technologies. It has obtained an exclusive worldwide license to a proprietary technology developed at the MS Patient Care and Research Clinic at the University of Alberta for the treatment of MS. The technology, dirucotide, is a synthetic myelin basic protein peptide comprised of 17 amino acids which is intravenously injected (every six months) into MS patients as a therapeutic treatment. |
|
| Products / Services |
BioMS Medicals lead product, MBP8298 is based on over 26 years of research, has been administered over 12 years to MS patients, and has successfully completed Phase I and II human clinical trials. MBP8298 is currently in a pivotal Phase II/III clinical trial for secondary progressive MS.
|
|
| Market / Customers |
The market opportunity for MBP8298 is over $10 billion a year. Multiple Sclerosis is thought to affect approximately 2.5 million people worldwide
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
